logo-loader

Dyadic touts recent collaborations, 3Q highlights at Jefferies London Healthcare Conference

Last updated: 13:05 18 Nov 2019 EST, First published: 08:05 18 Nov 2019 EST

Dyadic International Inc (NASDAQ:DYAI) CEO Mark Emalfarb and CCO Matthew Jones tell Proactive's Andrew Scott the duo are in London for the Jefferies London Healthcare Conference, the biotech's third year attending. 

Emalfarb and Jones say the Florida-based biotech is touting its recent collaboration with a leading animal health company, as well as its recent 3Q highlights. Dyadic will have a presence later this week at the Protein And Antibody Engineering Summit in Lisbon.

Alvopetro posts 86% net back margin as Q2 volumes jump 26% and Murucututu...

Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF, FRA:A6Y0) CEO Corey Ruttan tells Proactive's Stephen Gunnion that Q2 2026 sales volumes averaged 3,067 barrels of oil equivalent per day, up 26% year-on-year, with revenue of just over $19 million and funds flow from operations of $14.1...

22 hours, 21 minutes ago